Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Cell Adhesion & Migration

NOP2/Sun domain 4-mediated m5C methylation of Janus kinase 1 promotes hepatocellular carcinoma progression

  1. 1Department of Hepatobiliary And Pancreatic Vascular Surgery, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China
  2. 2Department of General Surgery, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China
  3. 3Department of Hepatopancreatobiliary Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, China

Abstract

5-methylcytosine (m5C) modification is associated with various cancers, but the role of NOP2/Sun domain 4 (NSUN4)-mediated m5C modification in hepatocellular carcinoma (HCC) remains unclear. Here, NSUN4 was markedly upregulated in HCC and correlated with poor survival. Silencing NSUN4 suppressed HCC cell proliferation, migration, invasion and tumor growth. Mechanistically, NSUN4 enhanced JAK1 mRNA stability and expression through m5C methylation, activating JAK-STAT3 signaling and driving malignant progression. Thus, NSUN4 promotes HCC progression via m5C-dependent JAK1 stabilization and JAK-STAT3 activation, highlighting NSUN4 as a promising therapeutic target for HCC.

Related

  1. The Role of METTL3-Mediated m⁶A Methylation in Hepatocellular Carcinoma Progression and Treatment.
    Bala Gamage Nalaka Hasith Maduranga, Hee Doo Yang, Su In Lee +4
    EpigenomesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  2. RBM15/IGF2BP1-mediated m 6A methylation of AKR1B10 promotes the progression of cervical squamous cell carcinoma
    义波 陈, 元娜 姜, 前 王 +4
    Journal of Central South University Medical SciencesPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationPMC
  3. NEDD4 Promotes Hepatocellular Carcinoma Progression Through Ubiquitin-Dependent Degradation of EPHB6.
    Guowei Zhang, Mengxuan Ji, Zhiyi Liu +8
    Cancer sciencePeer-reviewedCC BY-NCFull textMolecular biology & gene regulationEurope PMCPMC
  4. SFPQ Promotes Hepatocellular Carcinoma Progression by Affecting GTF2H3 Splicing Variants
    Qin Tang, Siyuan Chen, Xueying Chen +2
    CancersPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  5. Metformin Attenuates Glucose-Driven Hepatocellular Carcinoma Progression by Targeting GPD2-Mediated Metabolic Plasticity.
    Supakant Siripongsampan, Manusanun Kateyai, Kanadit Piriyapairoje +6
    ScientificaPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCPMC
BibTeX
@article{ke2026nop2sun,
  title = {{NOP2/Sun domain 4-mediated m5C methylation of Janus kinase 1 promotes hepatocellular carcinoma progression}},
  author = {Jingpeng Ke and Yiwen Xu and Fadian Ding and Yiping Chen and Zhimin Li and Jingxi Chen},
  journal = {Cell Adhesion \& Migration},
  year = {2026},
  month = nov,
  doi = {10.1080/19336918.2026.2757921},
  url = {https://doi.org/10.1080/19336918.2026.2757921},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - NOP2/Sun domain 4-mediated m5C methylation of Janus kinase 1 promotes hepatocellular carcinoma progression
AU  - Jingpeng Ke
AU  - Yiwen Xu
AU  - Fadian Ding
AU  - Yiping Chen
AU  - Zhimin Li
AU  - Jingxi Chen
PY  - 2026
DA  - 2026/11/04
JO  - Cell Adhesion & Migration
DO  - 10.1080/19336918.2026.2757921
UR  - https://doi.org/10.1080/19336918.2026.2757921
AB  - 5-methylcytosine (m5C) modification is associated with various cancers, but the role of NOP2/Sun domain 4 (NSUN4)-mediated m5C modification in hepatocellular carcinoma (HCC) remains unclear. Here, NSUN4 was markedly upregulated in HCC and correlated with poor survival. Silencing NSUN4 suppressed HCC cell proliferation, migration, invasion and tumor growth. Mechanistically, NSUN4 enhanced JAK1 mRNA stability and expression through m5C methylation, activating JAK-STAT3 signaling and driving malignant progression. Thus, NSUN4 promotes HCC progression via m5C-dependent JAK1 stabilization and JAK-STAT3 activation, highlighting NSUN4 as a promising therapeutic target for HCC.
SN  - 1933-6918
SN  - 1933-6926
ER  -